These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 9114206)

  • 1. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
    Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
    Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
    Xin X; Jian L; Xia X; Jia B; Huang W; Li C; Wang C; Zhou L; Sun X; Tang X; Huang Y; Zhu Y; Zhang W
    Ann Clin Microbiol Antimicrob; 2013 Dec; 12():38. PubMed ID: 24321187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
    Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
    J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
    Fuchs PC; Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 Sep; 8(1):61-5. PubMed ID: 3501975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of sulbactam/cefoperazone for lower respiratory tract infections. Correlation between the efficacy of sulbactam/cefoperazone and beta-lactamase].
    Koga H; Tomono K; Hirakata Y; Kohno S; Abe K; Kawamoto S; Kusano S; Tanaka K; Morikawa N; Sugiyama H; Katsumata T; Sasayama K; Shimoguchi K; Hashimoto A; Matsumoto Y; Inoue Y; Ishiguro M; Hori H; Mashimoto H; Dotsu Y; Tanaka H; Imamura Y; Kanda T; Hara K
    Jpn J Antibiot; 1996 Aug; 49(8):800-7. PubMed ID: 9053534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A randomized controlled clinical trial of sulperazone as compared with cefotaxime in the treatment of bacterial infections].
    Li J; Miao J; Hu W
    Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):680-2. PubMed ID: 8731830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
    Suzuki K; Horiba M
    Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on sulbactam/cefoperazone in urinary tract infections in elderly patients].
    Oyabu Y
    Jpn J Antibiot; 1996 Mar; 49(3):250-5. PubMed ID: 8935120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cefoperazone/sulbactam in neonates.
    Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A
    Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies of sulbactam/cefoperazone therapy in pediatric bacterial infections].
    Nakamura A; Himi K; Matsumura C; Suzuki H; Kurosaki T; Sugaya N; Terashima I; Uehara S
    Jpn J Antibiot; 1984 Oct; 37(10):1793-800. PubMed ID: 6094859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections.
    Jauregui LE; Appelbaum PC; Fabian TC; Hageage G; Strausbaugh L; Martin LF
    J Antimicrob Chemother; 1990 Mar; 25(3):423-33. PubMed ID: 2187014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies.
    Jones RN; Wilson HW; Thornsberry C; Barry AL
    Diagn Microbiol Infect Dis; 1985 Nov; 3(6):489-99. PubMed ID: 2998694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of cefoperazone and cefoperazone plus sulbactam in a neutropenic site model.
    Fasching CE; Moody JA; Sinn LM; Tenquist J; Gerding DN; Peterson LR
    Diagn Microbiol Infect Dis; 1991; 14(2):147-55. PubMed ID: 1873973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and clinical studies of sulbactam/cefoperazone in pediatric field].
    Nakashima T; Ueda S; Hayakawa F; Miyachi Y; Hakamada S; Kuno K
    Jpn J Antibiot; 1984 Oct; 37(10):1846-58. PubMed ID: 6094864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on sulbactam/cefoperazone in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
    Greenberg RN; Reilly PM; Weinandt WJ; Bollinger M; Kennedy DJ
    Clin Ther; 1987; 10(1):52-6. PubMed ID: 3329965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.
    Williams JD
    Clin Infect Dis; 1997 Mar; 24(3):494-7. PubMed ID: 9114205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.